Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.38 USD | -2.83% | -19.52% | -63.06% |
Mar. 21 | Dermata Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 05 | Wall Street Set to Open Lower as Monthly Jobs Data Much Stronger Than Expected | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.5M |
---|---|---|---|---|---|
Net income 2024 * | -13M | Net income 2025 * | -15M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.21
x | P/E ratio 2025 * |
-0.73
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.15% |
1 day | -2.83% | ||
1 week | -19.52% | ||
Current month | -31.11% | ||
1 month | -33.74% | ||
3 months | -52.06% | ||
6 months | -65.48% | ||
Current year | -63.06% |
Managers | Title | Age | Since |
---|---|---|---|
Gerry Proehl
CEO | Chief Executive Officer | 65 | 14-12-07 |
David Hale
FOU | Founder | 75 | 14-12-07 |
Kyri van Hoose
DFI | Director of Finance/CFO | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hale
FOU | Founder | 75 | 14-12-07 |
Gerry Proehl
CEO | Chief Executive Officer | 65 | 14-12-07 |
Wendell Wierenga
BRD | Director/Board Member | 76 | 16-09-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 3.38 | -2.83% | 19,942 |
24-05-23 | 3.478 | -3.91% | 26,029 |
24-05-22 | 3.62 | +5.89% | 42,554 |
24-05-21 | 3.418 | -9.08% | 228,420 |
24-05-20 | 3.76 | -10.48% | 44,542 |
Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.06% | 1.5M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- DRMA Stock